{"id":647,"date":"2024-12-19T21:20:47","date_gmt":"2024-12-19T21:20:47","guid":{"rendered":"https:\/\/simpathic.eu\/?page_id=647"},"modified":"2025-04-22T10:17:14","modified_gmt":"2025-04-22T10:17:14","slug":"news","status":"publish","type":"page","link":"https:\/\/simpathic.eu\/?page_id=647","title":{"rendered":"News"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

SIMPATHIC
News<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/strong><\/p>

\u00a0<\/strong><\/p>

SIMPATHIC is now described in the scientific literature!<\/strong><\/p>

The article gives a\u00a0comprehensive overview\u00a0of the large unmet medical needs of rare disease patients and SIMPATHIC\u2019s ultimate goal to accelerate drug repurposing for rare diseases.<\/p>

For the online version, click here<\/a><\/p>

For a download of the manuscript, click here<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Fundraising event for metabolic disorders in The Netherlands<\/strong><\/p>

In the Netherlands, metabolic diseases are the deadliest diseases among children: 1 in 4 does not live past the age of 18. This week, the Netherlands will hopefully take massive action for children with\u00a0 metabolic diseases through NPO 3FM Serious Request, \u00a0a multi-day, multimedia fundraising event for METAKIDS, a dutch foundation raising funds for research on metabolic diseases.\u00a0 SIMPATHIC’s coordinator Clara van Karnebeek participates in the daily TV talk show to raise funding for metabolic disorders.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Face-to-Face meeting\u00a0 in D\u00fcsseldorf<\/strong><\/p>

On 2 and 3 December 2024, the second SIMPATHIC F2F meeting was held in D\u00fcsseldorf, hosted by Prof. Dr. Alessandro Prigione from the Heinrich Heine University.\u00a0 Over 50 researchers, clinicians and partnering stakeholders discussed working progress and future plans with the ultimate goal to accelerate drug repurposing for rare diseases.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Repurpolis game\u00a0<\/strong><\/p>

During the SIMPATHIC meeting, all participants played the REPURPOLIS game that reflects the challenges in drug repurposing. This game was developed under the leadership of EATRIS. The game was introduced by the Dr. Rosan Kreeftmeijer-Vegter, DVM, PhD. With five groups, we first designed the pathway for a specific drug and then moved on this pathway, facing successes and disappointments. Like in the real world, some groups were successful in obtaining market authorization, some were not. Want to play the REPORPOLIS\u00a0 game yourself?\u00a0 Visit the webpage at EATRIS;\u00a0 https:\/\/eatris.eu\/repurpolis\/<\/a><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

SIMPATHIC News \u00a0 \u00a0 SIMPATHIC is now described in the scientific literature! The article gives a\u00a0comprehensive overview\u00a0of the large unmet medical needs of rare disease patients and SIMPATHIC\u2019s ultimate goal to accelerate drug repurposing for rare diseases. For the online version, click here For a download of the manuscript, click here Fundraising event for metabolic […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-647","page","type-page","status-publish","hentry"],"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/pages\/647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/simpathic.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=647"}],"version-history":[{"count":32,"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/pages\/647\/revisions"}],"predecessor-version":[{"id":701,"href":"https:\/\/simpathic.eu\/index.php?rest_route=\/wp\/v2\/pages\/647\/revisions\/701"}],"wp:attachment":[{"href":"https:\/\/simpathic.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}